Dublin, Aug. 22, 2017 -- The "United States Proton Therapy Market & Forecast, Reimbursement Policy, Patients Treated at Proton Therapy Centers" report has been added to Research and Markets' offering.
The potential market of proton therapy in United States would be more than US$ 15 Billion by the end of 2021 and it is expected to grow with a CAGR of 6.04 percent in future.
At present the United States holds world's 40 percent of Proton Beam Therapy Facility. In recent time, more research institutes and hospitals are investing in proton therapy to make the technology more accessible to patients.
In this report we have studied the market in two parts: a) Actual Market and b) Potential Market. The report also talks about list of all operational and future Proton Therapy centers; Economics of proton therapy including reimbursement policies. Proton Therapy revenues from 3 companies (IBA, Varian Medical Systems, Elekta) has also been studied in the report.
a) Actual Market is the current market which is already present
b) Potential Market is the market which can be achieved; but it has yet not been achieved due to demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year.
United States Proton Therapy Market has been analyzed from four view points:
- United States Proton Therapy Actual Market & Forecast (2009 - 2021)
- United States Proton Therapy Untapped Market & Forecast (2009 - 2021)
- United States Proton Therapy Treated Patient Volume & Forecast (2009 - 2021)
- United States Proton Therapy Untapped Patient Volume & Forecast (2009 - 2021)
Key Topics Covered:
1. Executive Summary
2. United States Proton Therapy Market - Actual & Potential Market
2.1 United States - Proton Therapy Market
2.2 United States - Potential Proton Therapy Market & Forecast
3. United States Proton Therapy Patient Number - Actual and Potential
3.1 United States - Patients Treated with Proton Therapy Actual Numbers & Forecast
3.2 United States - Patients with Proton Therapy Potential Numbers & Forecast
4. United States - List of Proton Therapy Centers
5. United States - Proton Therapy Treated Patients by Centers
5.1 Loma Linda (LLUMC) Proton Therapy Center - Number of Patients Treated (2008 - 2014)
5.2 UCSF - CNL Proton Therapy Center - Number of Patients Treated (2008 - 2015)
5.3 Boston (NPTC) Proton Therapy Center - Number of Patients Treated (2008 - 2015)
5.4 Bloomington (MPRI, 2) Proton Therapy Center - Number of Patients Treated (2008 - 2014)
5.5 Houston (MD Anderson) Proton Therapy Center - Number of Patients Treated (2008 - 2015)
5.6 UFPTI Jacksonville Proton Therapy Center - Number of Patients Treated (2008 - 2015)
5.7 Oklahoma City (ProCure PTC) Proton Therapy Center - Number of Patients Treated (2009 - 2015)
5.8 CDH Warrenville Proton Therapy Center - Number of Patients Treated (2010 - 2015)
5.9 Philadelphia (Upenn) Proton Therapy Center - Number of Patients Treated (2011 - 2015)
5.10 Hampton (HUPTI) Proton Therapy Center - Number of Patients Treated (2012 - 2015)
5.11 New Jersey (ProCure PTC) Proton Therapy Center - Number of Patients Treated (2012 - 2015)
5.12 Seattle (SCCA ProCure PTC) Proton Therapy Center - Number of Patients Treated (2013 - 2015)
5.13 St. Louis (S. Lee King PTC) Proton Therapy Center - Number of Patients Treated (2013 - 2015)
5.14 Provision Center for Proton Therapy, Knoxville, TN - Number of Patients Treated (2014 - 2015)
5.15 San Diego (Scripps PTC) - Number of Patients Treated (2014 - 2015)
5.16 Shreveport (Willis Knighton) Proton Therapy Center - Number of Patients Treated (2014 - 2015)
5.17 Jacksonville (Ackerman CC) Proton Therapy Center - Number of Patients Treated (2015)
5.18 Rochester (Mayo PBTC) Proton Therapy Center - Number of Patients Treated (2015)
5.19 Brunswick (Laurie PC) Proton Therapy Center - Number of Patients Treated (2015)
5.20 Irving (Texas Center for PT) Proton Therapy Center - Number of Patients Treated (2015)
5.21 Memphis (St. Jude PTC) Proton Therapy Center - Number of Patients Treated (2015)
6. Proton Therapy - Reimbursement Policies
6.1 Proton Therapy Reimbursement Policies for Patients
6.2 Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers
7. Components of a Standard Proton Therapy Center
7.1 Proton Accelerator
7.1.1 Synchrotrons (example: LLUMC at Loma Linda)
7.1.2 Cyclotrons (example: MGH Boston)
7.1.3 Synchrocyclotrons (examples: Orsay, Uppsala)
7.1.4 Linacs (Rome)
7.1.5 H-minus Synchrotrons
7.1.6 Separated Sector Cyclotrons
7.1.7 Super-conducting Cyclotrons
7.1.8 Fast Cycling Synchrotron
7.2 Beam Transport System
7.3 Beam Delivery System
7.3.1 The Passive Scattering Technique
7.3.2 Beam Scanning
7.4 Nozzle
7.4.1 Single Scattering
7.4.2 Double Scattering
7.4.3 Uniform Scanning Nozzle
7.4.4 Pencil Scanning Nozzle
7.5 Treatment Planning System
7.6 Image Viewers
7.7 Patient Positioning System (PPS)
7.8 Human Resource
8. Global Proton Therapy - Company Analysis (2010-2021)
8.1 IBA Proton Therapy
8.1.1 Sales Analysis
8.2 Varian Medical Systems
8.2.1 Sales Analysis
8.3 Elekta
8.3.1 Sales Analysis
9. Proton Therapy - Driving Factors
9.1 Technology Advancement
9.2 Growing Incidence of Cancer Patients in United States
10. Proton Therapy - Challenges
10.1 Requires Huge Investment
10.2 Operations Challenges
Companies Mentioned
- Elekta
- IBA
- Varian Medical Systems
Proton Therapy Centers:
- Bloomington (MPRI, 2)
- Boston (NPTC)
- Brunswick (Laurie PC)
- CDH Warrenville
- Hampton (HUPTI)
- Houston (MD Anderson)
- Irving (Texas Center for PT)
- Jacksonville (Ackerman CC)
- Loma Linda (LLUMC)
- Memphis (St. Jude PTC)
- New Jersey (ProCure PTC)
- Oklahoma City (ProCure PTC)
- Philadelphia (Upenn)
- Provision Center for Proton Therapy, Knoxville, TN
- Rochester (Mayo PBTC)
- San Diego (Scripps PTC)
- Seattle (SCCA ProCure PTC)
- Shreveport (Willis Knighton)
- St. Louis (S. Lee King PTC)
- UCSF - CNL
- UFPTI Jacksonville
For more information about this report visit https://www.researchandmarkets.com/research/7d8bt5/united_states
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Nuclear Medicine and Radiopharmacology


Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Instagram Outage Disrupts Thousands of U.S. Users
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Washington Post Publisher Will Lewis Steps Down After Layoffs
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



